Landscapes / Targets
PRMT5
12 drugs act on PRMT5, in 31 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs12
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Bristol Myers Squibb · Public BMY |
Phase 2/3 | 15 Aug 2028Phase 2 trial completes | ||
| Next date | 15 Aug 2028 · Phase 2 trial completes | ||||
| Also tested for | Mesothelioma, Non Small Cell Lung Cancer and 10 more | ||||
| Open drug page | |||||
— |
Amgen · Public AMGN |
Phase 2 | 30 Nov 2026soonPhase 1/2 trial completes | ||
| Next date | 30 Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced MTAP-null Solid Tumors, Thoracic Tumors and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Mar 2027Phase 1/2 trial completes | |||
| Next date | 31 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme and 5 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 1 May 2027Phase 1/2 trial completes | |||
| Next date | 1 May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | PDAC, PDAC - Pancreatic Ductal Adenocarcinoma and 8 more | ||||
| Open drug page | |||||
— |
AstraZeneca · Public AZN |
Phase 1/2 | 4 Dec 2028Phase 1/2 trial completes | ||
| Next date | 4 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors That Are MTAP Deficient, Lymphoma and 6 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 18 Jun 2029Phase 1/2 trial completes | |||
| Next date | 18 Jun 2029 · Phase 1/2 trial completes | ||||
| Also tested for | MTAP-deleted Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | 31 Mar 2030Phase 1/2 trial completes | |||
| Next date | 31 Mar 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Brain Metastases From Solid Tumors, Leptomeningeal Disease and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Jun 2027Phase 1 trial completes | |||
| Next date | 30 Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | HR+ / HER2- Advanced Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Jul 2027Phase 1 trial completes | |||
| Next date | 1 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | Oct 2027Phase 1 trial completes | |||
| Next date | Oct 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor, Non Hodgkin Lymphoma | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Solid Tumors and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Apr 2028Phase 1 trial completes | |||
| Next date | 30 Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC) and 11 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 12 of 12 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026